Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

    Not recruiting

    1 1 1
    Investigated drugs:
    France
  • Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer

    Not recruiting

    1 1 1
    Belgium France Germany Italy Poland Portugal +1
  • Study of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Denmark Finland France Germany Italy +3
  • Study comparing brigatinib alone versus brigatinib with carboplatin and pemetrexed combination as first treatment for patients with advanced ALK-positive lung cancer

    Not recruiting

    1 1 1
    France
  • Long-Term Safety Study of Riliprubart in Patients with Cold Agglutinin Disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy The Netherlands
  • Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy The Netherlands +2
  • Study on MK-6194 for Adults with Systemic Lupus Erythematosus

    Not recruiting

    1 1
    Investigated drugs:
    France Italy Poland Spain
  • Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium Germany Spain Sweden